StonvexLoading…
StonvexStonvexStonvexCore line items from PII's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.15B | $7.18B | $8.93B | $8.59B |
Operating Income | $-348.70M | $290.60M | $700.90M | $804.50M |
Net Income | $-465.50M | $110.80M | $502.80M | $447.10M |
EPS (Diluted) | $-8.18 | $1.95 | $8.71 | $7.44 |
Total Assets | $4.89B | $5.53B | $5.52B | $5.22B |
Total Liabilities | $4.05B | $4.22B | $4.09B | $4.10B |
Cash & Equivalents | $138.00M | $287.80M | $367.80M | $324.50M |
Free Cash Flow OCF − CapEx | $558.10M | $6.50M | $513.20M | $202.00M |
Shares Outstanding | 56.50M | 56.10M | 56.50M | 57.00M |